Press release
Global Cutaneous & Systemic Leishmaniasis Market will reach US$ 411 Million by 2028 at a CAGR of 2.90%
The market for cutaneous and systemic leishmaniasis drugs includes pentavalent antimonials as well as antifungal and anti leishmaniasis medications. These medications are mainly available as oral medications, injectables, and topical medications and extensively used to treat cutaneous and systemic leishmaniasis.
Want Insights To Cutaneous And Systemic Leishmaniasis Market? Ask For Sample! https://www.persistencemarketresearch.com/samples/28225
Companies
GlaxoSmithKline plc.
Gilead Sciences, Inc.
Profounda Pharmaceuticals
Knight Therapeutics Inc.
Janssen Global Services, LLC
Albert David Ltd
Jubilant Life Sciences Ltd.
Novartis AG
Sanofi
Endo Pharmaceuticals Inc
Bristol-Myers Squibb Company
United Biotech Pvt. Ltd.
Planning To Conclude Your Strategy On A Decisive Note In The Cutaneous And Systemic Leishmaniasis Market? Glance Through The "Methodology" Implied! https://www.persistencemarketresearch.com/methodology/28225
Factors such as increased global healthcare expenditure, higher per capita income, and increased investment in research and development are likely to fuel the cutaneous and systemic leishmaniasis market. Furthermore, increased awareness about the treatment and prevention of tropical illnesses, as well as reimbursement policies to cover treatment-related expenditures, are likely to drive market expansion.
In terms of geography, due to the high prevalence of cutaneous and systemic leishmaniasis, Latin America, APEJ, and MEA are likely to dominate the Global Cutaneous & Systemic Leishmaniasis Market. Because of the high proportion of disease occurrence in these regions, the demand for drug-based products is expected to increase significantly in the coming years.
Want More Insights?
PMR has presented a comprehensive report based on Cutaneous & Systemic Leishmaniasis Market as per Drug Class (Pentavalent Antimonials, Antifungal Drugs, and Anti-Lesihmanial/Antimicrobial Drugs), Route of Administration (Oral, Injectable, and Topical), Indication (Cutaneous Leishmaniasis, Mucosal Leishmaniasis, and Visceral Leishmaniasis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies) based on seven regions.
Access Full report- https://www.persistencemarketresearch.com/checkout/28225
Access PMR Exclusive Reports-
Facial Rejuvenation Market- https://www.persistencemarketresearch.com/market-research/facial-rejuvenation-market.asp
Stromal Vascular Fraction Market- https://www.persistencemarketresearch.com/market-research/stromal-vascular-fraction-market.asp
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cutaneous & Systemic Leishmaniasis Market will reach US$ 411 Million by 2028 at a CAGR of 2.90% here
News-ID: 2717939 • Views: …
More Releases from Persistence Market Research
Europe Calf Milk Replacer Market to Reach US$1,657.2 Mn by 2032 | Driven by Risi …
The Europe calf milk replacer market is poised for significant growth over the coming years. The market size is projected to reach US$1,018.6 million in 2025 and is anticipated to expand to US$1,657.2 million by 2032, registering a robust compound annual growth rate (CAGR) of 7.2% during the forecast period from 2025 to 2032. The growth trajectory is driven by the increasing awareness among dairy farmers regarding the nutritional requirements…
Croscarmellose Sodium Market to Reach $487 Mn by 2032, Driven by Rising Pharma D …
The global croscarmellose sodium market is projected to witness significant expansion over the forecast period, reflecting the growing adoption of pharmaceutical excipients across diverse applications. Valued at approximately US$ 288.7 million in 2025, the market is expected to reach US$ 487.0 million by 2032, registering a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032. This growth trajectory is driven primarily by increasing demand for orally disintegrating tablets…
Europe Egg Replacement Ingredients Market to Reach $1,711.1 Mn by 2032, Driven b …
The Europe egg replacement ingredients market is witnessing significant expansion, driven by the increasing adoption of plant-based diets and rising consumer awareness regarding health and wellness. The market size is projected to reach US$ 952.2 million in 2025 and is expected to surge to US$ 1,711.1 million by 2032, registering a robust CAGR of 8.7% over the forecast period from 2025 to 2032. The growing demand for clean-label products, vegan…
Kraft Paper Market to Reach US$ 25.0 Billion by 2032: Growth Driven by Rising De …
The global Kraft Paper market is undergoing significant expansion, driven by the accelerating shift toward eco-friendly packaging materials and the rising global awareness surrounding sustainability. As industries worldwide transition from plastic-based packaging to biodegradable alternatives, kraft paper has emerged as one of the most sought-after materials due to its strength, recyclability, and versatility.
According to the latest study by Persistence Market Research, the global Kraft Paper market size is projected to…
More Releases for Leishmaniasis
Visceral Leishmaniasis Market Generated Opportunities, Future Scope 2025-2032
The most recent report published by WMR indicates that the "Visceral Leishmaniasis Market" is likely to accelerate significantly in the next few years. The Visceral Leishmaniasis Market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The Visceral Leishmaniasis Market study includes information on market factors such as the market dynamics, drivers, restraints, challenges,…
Visceral Leishmaniasis Market Share, Size, Trends and Global Forecast
The Visceral Leishmaniasis Treatments Market Is Set To Grow At An Estimated CAGR Of 6.6% From 2025 To 2034, Rising From $580 Million In 2024 To $1.1 Billion By 2034.
On April 15, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Visceral Leishmaniasis market goods. The market study excludes key regions that are accelerating marketization. This…
Leishmaniasis Treatment Market Analysis and Future Prospects for 2030
The world of the leishmaniasis treatment market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing environment.…
Leishmaniasis Treatment Market Outlook 2021-2027- Sales Revenue, Industry Growt …
The global market for leishmaniasis therapy can be divided into three categories: drug type, diagnostic method, and vector control method. Leishmaniasis is a parasitic disease caused by Leishmania. The Leishmania parasite is a single-celled protozoan that is spread through the bite of an infected female phlebotomine sand fly. Use of nets or mesh, sprays, and pesticides effective against sandflies are all examples of market segmentation by vector control strategies.
Leishmaniasis Treatment…
Global Leishmaniasis Treatment Market 2020 Industry Status
This report also researches and evaluates the impact of Covid-19 outbreak on the Leishmaniasis Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Leishmaniasis Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Global Leishmaniasis Treatment Market Overview:
The global Leishmaniasis Treatment market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report,…
Leishmaniasis Treatment Market to Witness Robust Expansion by 2024
LP INFORMATION offers a latest published report on Leishmaniasis Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Leishmaniasis Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,…
